In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-18 of 18 for your search:
Drug:  oblimersen sodium
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 60 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02805, CALGB-10201, CDR367323, U10CA031946, NCT00085124

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AGENDA, GM307, NCT00518895

3.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000271308, U01CA069853, P30CA054174, SACI-IDD-02-23, NCI-5793, 5793, NCT00055822

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01437, MC0285, MAYO-MC0285, NCI-5826, CDR0000304634, N01CM17104, 5826, NCT00062244

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GL217, NCT00078234

6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02600, 12975A, N01CM62201, CDR0000371904, UCCRC-12975A, 6243, NCI-6243, NCT00086944

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000257565, PMH-PHL-011, NCI-5798, 5798, NCT00047229

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02790, CALGB 10107, U10CA031946, NCT00049192

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-00617, ID02-148, N01CM17003, N01CM62202, N01CM17107, N01CM62203, MDA-ID-02148, NCI-5808, 5808, NCT00054639

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 19 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02828, PHII-42, 5828, N01CM17101, CCC-PHII-42, CHNMC-PHII-42, NCI-5828, NCT00059813

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01446, 03-105, CDR0000354418, NCI-5907, MSKCC-03105, N01CM62207, N01CM62206, 5907, NCT00079131

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-30021, AVENTIS-AVE3139E/2501, NCT00085228

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000258058, MSGCC-210421, NCI-5824, 5824, NCT00049374

14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00010, CO 02904, NCI-5912, WCCC-CO-02904, U01CA062491, NCT00054548

15.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000329985, BCCA-NCI-5818, NCI-5818, 5818, NCT00070083

16.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GM108, NCT00409383

17.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GPK109, NCT00636545

18.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0307016, GENTA-GM214, NCT00070343
New Search